Decreased Expression and Aberrant Methylation of Raf Kinase Inhibitory Protein Gene in Esophageal Squamous Cell Carcinoma

REFERENCES

• Shahbaz Sarwar CM, Luketich JD, Landreneau RJ, Abbas G. Esophageal cancer: an update. Int J Surg 2010;8(6): 417–422.
   PubMedGoogle Scholar
• Guo W, Zhou RM, Wan LL, Wang N, Li Y, Zhang XJ, Dong XJ. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and C and risk of esophageal squamous cell carcinoma in a population of high incidence region of North China. J Cancer Res Clin Oncol 2008:134(2):263–270.
   PubMed Web of Science ®Google Scholar
• Wu DL, Sui FY, Jiang XM, Jiang XH. Methylation in esophageal carcinogenesis. World J Gastroenterol 2006;12(43):6933–6940.
   PubMed Web of Science ®Google Scholar
• Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM, Kolch W. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999;401(6749):173–177.
   PubMed Web of Science ®Google Scholar
• Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 2000;351(pt. 2):289–305.
   PubMed Web of Science ®Google Scholar
• Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 2005;6(11):827–837.
   PubMed Web of Science ®Google Scholar
• Hagan S, Garcia R, Dhillon A, Kolch W. Raf kinase inhibitor protein regulation of raf and MAPK signaling. Methods Enzymol 2006;407:248–259.
   PubMed Web of Science ®Google Scholar
• Keller ET, Fu Z, Brennan M. The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol 2004;68(6):1049–1053.
   PubMed Web of Science ®Google Scholar
• Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 2003;95(12):878–889.
   PubMed Web of Science ®Google Scholar
• Chatterjee D, Bai Y, Wang Z, Beach S, Mott S, Roy R, Braastad C, Sun Y, Mukhopadhyay A, Aggarwal BB, Darnowski J, Pantazis P, Wyche J, Fu Z, Kitagwa Y, Keller ET, Sedivy JM, Yeung KC. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 2004;279(17):17515–17523.
   PubMed Web of Science ®Google Scholar
• Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, García JJ, Kolch W. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 2005;11(20):7392–7397.
   PubMed Web of Science ®Google Scholar
• Li HZ, Gao Y, Zhao XL, Liu YX, Sun BC, Yang J, Yao Z. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res 2009;7(6): 832–840.
   PubMed Web of Science ®Google Scholar
• Li HZ, Wang Y, Gao Y, Shao J, Zhao XL, Deng WM, Liu YX, Yang J, Yao Z. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 2008;6(6):917–928.
   PubMed Web of Science ®Google Scholar
• Schuierer MM, Bataille F, Hagan S, Kolch W, Bosserhoff AK. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 2004;64(15):5186–5192.
   PubMed Web of Science ®Google Scholar
• Park S, Yeung ML, Beach S, Shields JM, Yeung KC. RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene 2005;24(21):3535–3540.
   PubMed Web of Science ®Google Scholar
• Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, Jass JR, Lugli A. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol 2007;127(5):820–827.
   PubMed Web of Science ®Google Scholar
• Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, Going JJ, García JJ, Scott L, Fyfe N, Murray GI, Kolch W. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 2006;24(36):5672–5679.
   PubMed Web of Science ®Google Scholar
• Lee HC, Tian B, Sedivy JM, Wands JR, Kim M. Loss of raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 2006;131(4):1208–1217.
   PubMed Web of Science ®Google Scholar
• Schuierer MM, Btaille F, Weiss TS, Hellerbrand C, Bosserhoff AK. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep 2006;16(3):451–456.
   PubMed Web of Science ®Google Scholar
• Al-Mulla F, Hagan S, Al-Ali W, Jacob SP, Behbehani AI, Bitar MS, Dallol A, Kolch W. Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol 2008;61(4):524–529.
   PubMed Web of Science ®Google Scholar
• Nguyen CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G, Jones PA. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-Aza-2’-deoxycytidine. Cancer Res 2002;62(22): 6456–6461.
   PubMed Web of Science ®Google Scholar
• Guo W, Dong Z, Chen Z, Yang Z, Wen D, Kuang G, Guo Y, Shan B. Aberrant CpG Island hypermethylation of RASSF1A in gastric cardia adenocarcinoma. Cancer Invest 2009;27(4):459–465.
   PubMed Web of Science ®Google Scholar
• Bouras T, Southey MC, Venter DJ. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res 2001;61(3):903–907.
   PubMed Web of Science ®Google Scholar
• Bernier I, Tresca JP, Jolles P. Ligand-binding studies with a 23 kDa protein purified from bovine brain cytosol. Biochim Biophys Acta 1986;871(1):19–23.
   PubMed Web of Science ®Google Scholar
• Granovsky AE, Rosner MR. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res 2008;18(4):452–457.
   PubMed Web of Science ®Google Scholar
• Klysik J, Theroux SJ, Sedivy JM, Moffit JS, Boekelheide K. Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal 2008;20(1):1–9.
   PubMed Web of Science ®Google Scholar
• Zhang L, Fu Z, Binkley C, Giordano T, Burant CF, Logsdon CD, Simeone DM. Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery 2004;136(3):708–715.
   PubMed Web of Science ®Google Scholar
• Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W, Sedivy JM. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 2001;21(21):7207–7217.
   PubMed Web of Science ®Google Scholar
• Minoo P, Baker K, Goswami R, Chong G, Foulkes WD, Ruszkiewicz AR, Barker M, Buchanan D, Young J, Jass JR. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 2006;55(10):1467–1474.
   PubMed Web of Science ®Google Scholar
• Martinho O, Gouveia A, Silva P, Pimenta A, Reis RM, Lopes JM. Loss of RKIP expression is associated with poor survival in GISTs. Virchows Arch 2009;455(3):277–284.
   PubMed Web of Science ®Google Scholar